Browse diseases

… of BP and mucosal eosinophilia (ME) (BP+ME) in differentiating ulcerative colitis (UC), Crohn’s disease (CD) and GITB using endoscopic mucosal bi…

…nit inhibitor, demonstrated efficacy in participants (pts) with ulcerative colitis (UC) treated with intravenous (IV) or subcutaneous (SC) inducti…

… under-recognised but important component of quality of life in ulcerative colitis (UC). While inflammatory activity and psychological factors are…

…as studied in patients (pts) with moderately to severely active ulcerative colitis (UC) in Phase 2 studies. We present efficacy endpoints at week …

…tor approved for the treatment of moderately to severely active Ulcerative Colitis (UC). 1 2 We evaluated the real-world effectiveness of FIL by p…

….9). 37 (55.2%) patients had Crohn’s disease and 30 (44.8%) had ulcerative colitis. 48 (71.6%) were commenced on upadacitinib and 19 (28.4%) on fi…

…ome measures are increasingly used to assess disease control in ulcerative colitis (UC). However, the relationship between patient-reported diseas…

…acy and safety of icotrokinra in adults with moderate-to-severe ulcerative colitis (UC) in a phase 2b, randomized, double-blind, placebo-controlle…

…dies [1-3] in patients (pts) with moderately to severely active ulcerative colitis (UC). We report efficacy and safety of two Phase 3, 8-week, ABT…

…is (WGCNA) in a large population with moderate-to-severe active Ulcerative Colitis (UC, n=358) (UNIFI, Sands et al 2019). TM enrichment scores in …

…llow-up of 7 years (4-12), 77 patients (17.5%) developed CRN: 3 CRC, 5 HGD, 40 hrLGD, 25 lrLGD, 4 IND. Patients with high- and low-…

…ry condition of the gut leading to increased risk of developing colorectal cancer (CRC). IBD-induced CRC, termed colitis-associated cancer (CAC),…